Trials / Completed
CompletedNCT02060357
Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes (OCT-DES)
Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Barts & The London NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is a comparative evaluation of re-endothelailisation of the Integrity Resolute zotarolimus eluting stent (Medtronic) and of the Promus Element erolimus eluting stent (Boston Scientific), in patients with diabetes. We plan to compare endothelial coverage and neointimal proliferation using OCT and compare this data to published results from conventional stents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optical coherence tomography |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-02-12
- Last updated
- 2015-08-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02060357. Inclusion in this directory is not an endorsement.